Go Ad-Free
logoThe People's Perspective on Medicine

Aspirin Boosts Prostate Cancer Survival

Aspirin may also boost survival in men being treated for prostate cancer. In a study of over 5,000 men with localized prostate cancer, those taking aspirin or another anticoagulant called warfarin were much less likely to suffer metastatic disease. Over the decade the study lasted, those on anti-clotting compounds had a 4 percent chance of dying from their prostate cancer. Those who were not taking aspirin or warfarin had a 10 percent chance of dying during that time. Aspirin was the most beneficial, particularly for men with high-risk prostate cancers.
[American Society for Radiation Oncology annual meeting, San Diego, Nov. 1, 2010]

Rate this article
0- 0 ratings
About the Author
Terry Graedon, PhD, is a medical anthropologist and co-host of The People’s Pharmacy radio show, co-author of The People’s Pharmacy syndicated newspaper columns and numerous books, and co-founder of The People’s Pharmacy website. Terry taught in the Duke University School of Nursing and was an adjunct assistant professor in the Department of Anthropology. She is a Fellow of the Society of Applied Anthropology. Terry is one of the country's leading authorities on the science behind folk remedies..
Tired of the ads on our website?

Now you can browse our website completely ad-free for just $5 / month. Stay up to date on breaking health news and support our work without the distraction of advertisements.

Browse our website ad-free
Join over 150,000 Subscribers at The People's Pharmacy

We're empowering you to make wise decisions about your own health, by providing you with essential health information about both medical and alternative treatment options.